CVOTs on DPP-4i Data from TECOS, EXAMINE, SAVOR-TIMI53, CARMELINA, and CAROLINA showed that DPP-4i are non-inferior to the placebo or glimepiride relative to primary cardiovascular endpoints [17, 48, 49, 57, 58]
Some insurance plans do cover semaglutide, particularly for patients with a documented obesity or type 2 diabetes diagnosis
By Sidra Healthcare Team | Reviewed by a DHA-Licensed GP | Updated: April 2026 Skin aging is a natural process, but environmental stressors such as UV exposure, pollution, and dehydration can accelerate visible signs like wrinkles, fine lines, and loss of elasticity
Who Should Avoid GHRP-6 Some groups should not use GHRP-6 without close medical guidance, mainly because growth hormone affects blood sugar and because of its unproven long-term safety
Dan Wagener (2022)
Green tea extract may aid in weight loss, especially in conjunction with regular exercise, by boosting metabolic activity and promoting more effective fat burning